Venous Thrombosis (VT)

Amendment 003: The purpose of this amendment is to update the CLIN structure, add clauses, and attach Attachment E - Questions and Answers. We have also extended the question due date to close on 10/30/2026 at 1:00PM CST We have not answered all questions recieved at this time, answers are still in works, please continue to monitor SAM.gov for updates. Amendment 002: The purpose of this amendment is to fix admin errors on the CLIN. Please see SF30. Amendment 001: The purpose of this amendment is to correct a spelling error on documents from "Venus Thrombosis" to "Venous Thrombosis". __________________________________________________ Base Venous Thrombosis RFQ: This notice is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the FAR Part 12, Acquisition of Commercial Products and Commercial Services. This announcement constitutes the only solicitation; offers are being requested and a written solicitation will not be issued. This notice is being issued as a Request for Quotations (RFQ) under solicitation number 80JSC026Q0014 for Venous Thrombosis (VT) . The provisions and clauses in the RFQ are those in effect through FAC 2026-01 The NAICS Code and Size Standard are 541715 and 1000 Employees, respectively. The offeror must state in their offer their size status for this acquisition. All responsible sources may submit an offer which must be considered by the agency. Delivery to NASA/JSC is required within 30 days after receipt of order. Delivery must be free on board (FOB) Destination. The following clauses and provisions are incorporated; full text of the clauses and provisions may be accessed electronically at: FAR - FAR Overhaul - Part 52 | Acquisition.GOV NFS - https://www.hq.nasa.gov/office/procurement/regs/NFS.pdf Offerors must provide the information required by FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Serviceswhich is incorporated by reference. The items under this acqu